Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients
NCT00386373
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Leukemia
Interventions
DRUG:
Imatinib Mesylate
Sponsor
M.D. Anderson Cancer Center